0
0
Home » Medical Devices » Cardiovascular Devices

Transcatheter Mitral Valve Implantation Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030

The transcatheter mitral valve implantation market was valued at $6.4 million in 2021. Valvular heart disease is caused by a defect in one of the four heart valves and is common in industrialized countries. Since valvular heart disease primarily affects the elderly, the incidence rate is increasing with the aging population. Mitral regurgitation, also known as mitral insufficiency, is caused by insufficient systolic coaptation of the mitral valve leaflets along with a change in the pressure gradient between the atrium and left ventricle. It is common in developed countries and is one of the most frequent valve diseases in the US. It is the second most common type of heart valve disease in Europe, having a similar prevalence and incidence rate.

Transcatheter mitral valve implantation market overview

Transcatheter mitral valve implantation market overview

For more insights on this report, download a free report sample

What are the market dynamics in the transcatheter mitral valve implantation market?

A transcatheter mitral valve implantation device is expected to be a more durable option for the elimination of severe mitral valve regurgitation. Transcatheter mitral valve implantation (replacement) procedures are suitable for patients who have severe primary or functional MR as well for those who were once eligible for annuloplasty or surgical replacement, but the mitral valve degenerated. Once approved, TMVI devices might also be efficacious in treating mitral valve stenosis.

The prevalence of mitral regurgitation increases with the aging population and is higher in developed countries while developing countries are more affected by rheumatic heart diseases. Additionally, the prevalence of mitral valve stenosis is growing in the elderly population. If transcatheter mitral valve implantation devices receive approval for mitral regurgitation, they can also be further evaluated for mitral valve stenosis.

What is the regional outlook of the transcatheter mitral valve implantation market?

The key regions in the transcatheter mitral valve implantation market are North America, Europe, Asia Pacific, and South and Central America.

Transcatheter mitral valve implantation market in North America

Due to the increase in the burden of the aging population in North America and the high prevalence of mitral regurgitation, the market for transcatheter mitral valve implantation devices is expected to grow at a significant rate once the device receives approval.

Transcatheter mitral valve implantation market in Europe

The demand for transcatheter mitral valve implantation devices is high in Europe due to a high prevalence of mitral regurgitation cases. Most of the patients are not eligible for open-heart surgery and thus the demand for minimally invasive options for the treatment of mitral valve regurgitation is high. 

Transcatheter mitral valve implantation market in Asia Pacific

Although the Asia Pacific has a high prevalence of aging population, the mitral regurgitation prevalence is comparatively lower than the western countries. The need for aortic valve replacement devices is more in the region than for transcatheter mitral valve repair. Hence, the market will grow at a comparatively lower rate than the Eastern regions because of economic and regulatory factors.

Transcatheter mitral valve implantation market in South and Central America

If the device is approved, the market is expected to grow at a comparatively slower rate in South Central America due to the lack of adequate healthcare infrastructure facilities, the high cost of the device, complexity of the procedure, and lack of approval of the device in most countries in the region.

What are the key companies in the transcatheter mitral valve implantation market?

The key company in the transcatheter mitral valve implantation market is Abbott Laboratories.

Market Report Scope

Market size (Year – 2021) $6.4 million
Forecast period 2021-2030
Key regions North America, Europe, Asia Pacific, and South and Central America
Key companies Abbott Laboratories

Market Report Scope

This report provides:

  • Currently marketed Transcatheter Mitral Valve Implantation (TMVI) market and evolving competitive landscape.
  • Insightful review of the key industry trends.
  • Annualized total Transcatheter Mitral Valve Implantation (TMVI) market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices, and market values by segment.
  • Global, regional, and country-level market-specific insights.
  • Qualitative market-specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • SWOT analysis for Transcatheter Mitral Valve Implantation (TMVI) market.
  • Competitive dynamics insights and trends provided for the Transcatheter Mitral Valve Implantation (TMVI) market.
  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Reasons to Buy

  • Understand the impact of COVID-19 on the Transcatheter Mitral Valve Implantation market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the Transcatheter Mitral Valve Implantation market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Transcatheter Mitral Valve Implantation market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Transcatheter Mitral Valve Implantation market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Key Players

Abbott Laboratories

Table of Contents

 

Frequently Asked Questions

The transcatheter mitral valve implantation market was valued at $6.4 million in 2021.

 

 

 

 

The key regions in the transcatheter mitral valve implantation market are North America, Europe, Asia Pacific, and South and Central America.

The key company in the transcatheter mitral valve implantation market is Abbott Laboratories.

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports